BETHESDA, Maryland, March 1 (TNSJou) -- The U.S. Department of Health and Human Services' National Institute of Neurological Disorders and Stroke issued the following news release: Researchers from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), a  more

WASHINGTON, March 1 (TNSJou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release: Scientists from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other forms of dementia. ALS and  more